PharmacyCert

Mastering MTM Billing and Reimbursement Models for the CMTM Certified in Medication Therapy Management Exam

By PharmacyCert Exam ExpertsLast Updated: April 20267 min read1,719 words

Introduction: Navigating MTM Billing and Reimbursement Models

As of April 2026, the landscape of pharmacy practice continues to evolve, with Medication Therapy Management (MTM) services playing an increasingly vital role in patient care. For pharmacists preparing for the CMTM Certified in Medication Therapy Management exam, a deep understanding of MTM billing and reimbursement models is not just an advantage—it's a necessity. This topic bridges the gap between providing essential clinical services and ensuring the financial sustainability of those services. Without effective strategies for billing and reimbursement, even the most impactful MTM interventions cannot be widely implemented or sustained.

This mini-article will delve into the intricacies of MTM billing and reimbursement, exploring the codes, models, and critical considerations that every CMTM candidate must master. It’s a complex but crucial area, reflecting the ongoing shift in healthcare from a product-centric to a service-centric model. Your ability to comprehend and apply these principles will be directly tested on the exam, and more importantly, will be fundamental to your success as a certified MTM provider in practice.

Key Concepts: Decoding MTM Billing and Reimbursement

Successfully billing for MTM services requires a comprehensive understanding of various codes, payer types, and evolving reimbursement models. Let's break down the essential components:

Current Procedural Terminology (CPT) Codes

CPT codes are the backbone of billing for MTM services. Developed and maintained by the American Medical Association (AMA), these codes describe medical procedures and services. For MTM, time-based codes are predominantly used:

  • 99605: Medication Therapy Management service(s) initial 15 minutes, face-to-face with patient, in a time unit of 15 minutes, with assessment and intervention.
  • 99606: Medication Therapy Management service(s) subsequent 15 minutes, face-to-face with patient, in a time unit of 15 minutes, with assessment and intervention.
  • 99607: Medication Therapy Management service(s) additional 15 minutes (List separately in addition to code for primary service). This code is used for each additional 15 minutes beyond the initial 15 minutes (99605) or subsequent 15 minutes (99606).

Example: If a pharmacist spends 40 minutes providing an initial MTM service, they would bill 99605 (for the first 15 minutes) and 99607 x 2 (for the two additional 15-minute increments). It’s crucial to document the exact time spent, as billing for time not actually spent can lead to audits and penalties.

International Classification of Diseases, Tenth Revision (ICD-10) Codes

While CPT codes describe the *service* provided, ICD-10 codes describe the *diagnosis* or *medical necessity* for the service. These codes are used to justify why the MTM service was needed. For pharmacists, this often involves identifying drug therapy problems (DTPs) and relating them to a patient's underlying disease states or conditions. For instance, a patient with uncontrolled hypertension (I10) might receive MTM due to medication non-adherence (Z91.19).

Payer Types and Reimbursement Models

Reimbursement for MTM services varies significantly depending on the payer:

  • Medicare Part D: Mandated by CMS, Part D plans (through their Pharmacy Benefit Managers - PBMs) must offer MTM programs to beneficiaries meeting specific criteria (e.g., multiple chronic conditions, multiple Part D drugs, high drug costs). Reimbursement often occurs through direct contracts between pharmacies/pharmacists and PBMs, or as part of broader pharmacy network agreements. These programs are typically structured around Comprehensive Medication Reviews (CMRs) and Targeted Medication Reviews (TMRs).
    "The Centers for Medicare & Medicaid Services (CMS) continues to emphasize the critical role of MTM in optimizing health outcomes and reducing overall healthcare costs for Medicare Part D beneficiaries." - CMS Fact Sheet, 2026.
  • Medicaid: State-specific Medicaid programs may cover MTM services, but coverage varies widely. Some states offer fee-for-service models, while others integrate MTM into managed care organizations (MCOs) with capitated payments or performance-based incentives.
  • Commercial Payers: Private insurance companies often contract with PBMs or directly with providers for MTM services. Reimbursement models can include fee-for-service, per-patient-per-month (PMPM) payments, or performance-based incentives tied to quality metrics (e.g., HEDIS measures like medication adherence).
  • Alternative Payment Models (APMs): These value-based care models, such as Accountable Care Organizations (ACOs), Patient-Centered Medical Homes (PCMHs), bundled payments, and shared savings programs, are increasingly incorporating pharmacists and MTM services. Reimbursement for MTM in these models is often indirect, as pharmacists contribute to overall cost savings and quality improvements that benefit the larger healthcare entity.

Incident-to Billing

This is a critical concept for pharmacists, particularly in physician office settings. "Incident-to" billing allows pharmacists to bill for services under a physician's National Provider Identifier (NPI) and receive Medicare Part B reimbursement. However, strict criteria must be met:

  • The service must be an integral, although incidental, part of a physician's professional service.
  • The service must be commonly furnished in a physician's office or clinic.
  • The physician must provide direct supervision (meaning the physician is immediately available, not necessarily in the room).
  • The physician must initiate the patient's care and remain actively involved.

While valuable, incident-to billing has limitations and is not a universal solution for pharmacist reimbursement, especially for pharmacists practicing independently in community pharmacies.

The Push for Direct Provider Status

Pharmacists continue to advocate for direct provider status at the federal level, which would allow them to be recognized and reimbursed by Medicare Part B for covered services, similar to other healthcare providers. Achieving this would significantly streamline MTM billing and expand access to pharmacist-provided care.

Documentation: The Foundation of Reimbursement

Regardless of the payer or billing model, meticulous documentation is paramount. It serves multiple purposes:

  • Justification: Proves medical necessity and supports the billed CPT codes.
  • Communication: Facilitates care coordination with other healthcare providers.
  • Auditing: Provides evidence for payer audits.
  • Outcomes Tracking: Demonstrates the value of MTM services in improving patient health and reducing costs.

Common documentation platforms include electronic health records (EHRs), MTM-specific software (e.g., OutcomesMTM, Mirixa), and detailed SOAP notes (Subjective, Objective, Assessment, Plan).

How It Appears on the Exam

The CMTM exam will test your knowledge of MTM billing and reimbursement through various question styles, often scenario-based:

  • CPT Code Selection: You might be presented with a patient case describing an MTM encounter (e.g., initial 30-minute review, 20-minute follow-up) and asked to identify the correct CPT code(s) to bill.
  • Payer-Specific Requirements: Questions may differentiate between Medicare Part D, Medicaid, or commercial plans, asking about specific program mandates or reimbursement nuances.
  • Incident-to Scenarios: You could be given a situation where a pharmacist provides MTM in a physician's office and asked to determine if the service qualifies for "incident-to" billing based on supervision and service criteria.
  • Documentation Importance: Expect questions on what constitutes appropriate documentation, why it's critical, or what might be missing from a given documentation example.
  • Challenges and Future Trends: The exam might touch upon the barriers to MTM reimbursement or the implications of evolving models like value-based care or direct provider status for pharmacists.

Example Exam Question Style: "A pharmacist completes a 45-minute comprehensive medication review for a Medicare Part D beneficiary in a community pharmacy setting. Which CPT codes should be billed, assuming a direct contract with the PBM allows for this service?"

Study Tips for Mastering MTM Billing

Approaching this topic strategically will ensure you're well-prepared for the CMTM exam:

  1. Memorize CPT Codes: Understand the distinctions between 99605, 99606, and 99607, especially regarding initial vs. subsequent and time increments. Practice applying them to different time scenarios.
  2. Understand Payer Nuances: Create a table comparing Medicare Part D, Medicaid (general principles), and commercial payers in terms of MTM program requirements, common reimbursement methods, and target populations.
  3. Deep Dive into "Incident-to": Focus on the specific conditions for incident-to billing. What constitutes "direct supervision"? When is it appropriate for a pharmacist?
  4. Practice Documentation: While you won't be writing full SOAP notes on the exam, understand the key elements that *must* be included in MTM documentation to support billing and demonstrate medical necessity.
  5. Review CMS Guidelines: Familiarize yourself with the latest CMS MTM program requirements for Part D plans. This provides the foundational context for many MTM services.
  6. Utilize Practice Questions: Engage with CMTM Certified in Medication Therapy Management practice questions and free practice questions that specifically cover billing and reimbursement. This is the best way to test your application of knowledge.
  7. Stay Current: Reimbursement models are dynamic. While the exam focuses on established principles, an awareness of ongoing advocacy for direct provider status and the growth of value-based care will provide valuable context.

Common Mistakes to Watch Out For

Avoid these pitfalls to maximize your score on the MTM billing and reimbursement sections of the CMTM exam:

  • Incorrect CPT Code Application: Billing 99605 for a follow-up service or miscalculating additional 15-minute units (e.g., billing 99607 for every 15 minutes instead of *additional* 15 minutes after the initial/subsequent).
  • Insufficient or Inaccurate Documentation: Failing to link the MTM service to a patient's diagnosis (ICD-10), not clearly stating the time spent, or not detailing the interventions and recommendations.
  • Misunderstanding "Incident-to" Rules: Assuming incident-to billing applies to all pharmacist services or failing to recognize the strict supervision requirements.
  • Ignoring Payer-Specific Differences: Applying Medicare Part D rules to a commercial payer scenario, or vice-versa, when their requirements might differ significantly.
  • Overlooking Medical Necessity: Billing for an MTM service without clearly establishing the clinical need or potential drug therapy problems it addresses.
  • Lack of Follow-up Documentation: Failing to document the patient's response to interventions, which is crucial for demonstrating the ongoing value of MTM.

Quick Review / Summary

Mastering MTM billing and reimbursement models is non-negotiable for any pharmacist seeking CMTM certification. It represents the crucial link between providing high-quality patient care and ensuring the sustainability of those services. Remember these key takeaways:

  • CPT Codes (99605, 99606, 99607): Understand their application based on service type (initial/subsequent) and time spent.
  • ICD-10 Codes: Essential for demonstrating medical necessity and justifying the MTM service.
  • Payer Landscape: Differentiate between Medicare Part D, Medicaid, and commercial payers, recognizing their unique requirements and reimbursement structures.
  • Incident-to Billing: A specific pathway for pharmacists in physician offices, requiring strict adherence to supervision and service rules.
  • Documentation is King: Meticulous, accurate, and comprehensive documentation is the foundation for successful reimbursement and audit defense.
  • Future Focus: Be aware of the ongoing advocacy for direct provider status and the growing role of MTM in value-based care models.

By diligently studying these concepts and practicing with relevant scenarios, you'll not only be prepared to ace the CMTM exam but also equipped to navigate the financial complexities of MTM in your professional practice. For a more comprehensive overview, consult our Complete CMTM Certified in Medication Therapy Management Guide.

Frequently Asked Questions

What are the primary CPT codes used for MTM services?
The primary CPT codes are 99605 for initial MTM services (typically 15 minutes), 99606 for follow-up MTM services (typically 15 minutes), and 99607 for each additional 15 minutes beyond the initial or follow-up service.
How does Medicare Part D influence MTM reimbursement?
Medicare Part D mandates that prescription drug plans (PDPs) offer MTM programs to targeted beneficiaries. While specific reimbursement rates vary by plan, this mandate drives the demand for and structure of MTM services, often through PBMs or direct contracts with pharmacies.
What is 'incident-to' billing in the context of MTM?
Incident-to billing allows pharmacists (or other non-physician providers) to bill for services under a physician's National Provider Identifier (NPI) when the services are an integral, although incidental, part of a physician's professional service and are commonly furnished in a physician's office or clinic. Strict supervision rules apply, often requiring direct supervision by the physician.
Why is robust documentation critical for MTM billing?
Robust documentation is essential to justify medical necessity, support the billed CPT codes, demonstrate patient outcomes, and comply with payer audit requirements. It proves that the service was performed, outlines the interventions, and tracks progress, ensuring proper reimbursement and avoiding clawbacks.
What are some common challenges in MTM reimbursement?
Challenges include varying payer requirements, lack of direct provider status for pharmacists in many states, low reimbursement rates, administrative burden of documentation, and the need to consistently demonstrate value and positive patient outcomes to payers.
How do value-based care models impact MTM reimbursement?
Value-based care models shift focus from fee-for-service to outcomes-based payment. MTM services, which improve medication adherence, reduce adverse drug events, and lower healthcare costs, are well-positioned to contribute to shared savings or bundled payment arrangements, potentially offering new avenues for reimbursement through collaborative practice agreements.

Ready to Start Practicing?

Join 2,800+ pharmacy professionals preparing with PharmacyCert. Start with free practice questions.

Related Articles